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The interleukin-1 receptor-associated kinase (IRAK) was first described as a signal transducer for interleukin-1 (IL- The Toll/IL-1R 1 receptor family consists of a large number of transmembrane proteins with conserved intracellular domains. Structural distinctions in the extracellular domains of these proteins divide this superfamily into two subgroups: the Toll-like receptors (TLRs) with leucine-rich repeats and IL-1R-related proteins with immunoglobulin-like motifs (1; for review, see Refs. 2 and 3). All members of the Toll/IL-1R family with known functions are involved in host defense. For example, the proinflammatory and immune regulatory cytokines IL-1 and IL-18 signal through members of the IL-1R-related protein subfamily (4, 5; for review, see Refs. 6 and 7), whereas TLR-2 and TLR-4 have been shown recently to mediate cellular response to bacterial lipopolysaccharide (LPS) (8 -12) .
The signal transduction pathways initiated by Toll/IL-1R family members ultimately lead to the activation of members of the rel and AP-1 family of transcription factors (for review, see Refs. 2, 3, 7, and 13). The receptor proximal signaling events of the proinflammatory cytokine IL-1 have been studied in detail. The first signaling event for IL-1 is the ligand-induced complex formation of IL-1RI and IL-1RAcP (14 -17) . The adaptor protein MyD88 is next recruited to this complex (18 -20) , which in turn enables the association of the IL-1R-associated kinase (IRAK) (21) (22) (23) . IRAK gets highly phosphorylated (21, 24) , leaves the receptor complex, and interacts with TRAF6 (25) . The IRAK-TRAF6 interaction triggers kinase cascades that lead to the activation of IB kinases and c-Jun NH 2 -terminal kinase, which phosphorylate IB and c-Jun, respectively (for review, see Refs. 7, 26, and 27) .
Accumulating evidence indicates that several components of the IL-1 pathway are also utilized by other members of the Toll/IL-1R family. TLR-4 has been shown to interact with MyD88, IRAK, and TRAF6 upon overexpression (28, 29) . Dominant negative mutants of MyD88 and TRAF6 can block LPSinduced NF-B activation mediated by TLR-2 (9) as well as NF-B activation induced by TLR-4 overexpression (28, 29) . In addition, IL-18 induces IRAK phosphorylation and interaction with TRAF6 (30, 31) . Further evidence implicating IL-1 signaling components in the IL-18 pathway was provided by the observation that targeted disruption of the myd88 gene in mice results in a loss of response to both IL-1 and IL-18 (32) .
The role of IRAK in cytokine signaling is also supported by genetic studies. Embryonic fibroblasts derived from IRAK-deficient mice show reduced NF-B and c-Jun NH 2 -terminal kinase activities after IL-1 treatment (33) . IRAK knock-out mice are also severely compromised in IL-1-induced neutrophilia and IL-1-induced increase in serum levels of TNF and IL-6 (34). Furthermore, splenocytes derived from the IRAK knock-out mice produced significantly reduced amounts of interferon-␥ in response to IL-18 (34) . Nonetheless, in contrast to the phenotype of the MyD88 knock-out mice, IRAK-deficient mice retain partial IL-1 and IL-18 responses in all of the above mentioned assays, indicating the presence of a compensatory mechanism in animals.
An IRAK-related molecule designated IRAK-2 has been identified in a computer-assisted EST data base search (19) . IRAK-2 is able to interact with other IL-1 signal transducers and activate NF-B upon overexpression in 293 cells. Here we report the identification and characterization of a novel IRAKlike molecule that has both similarities and differences compared with other members of the IRAK family. Utilizing an IRAK-deficient cell line, we present evidence that both IRAK-2 and the newly identified IRAK-like molecule can provide functional redundancy in signal transduction by the Toll/IL-1R receptor family.
MATERIALS AND METHODS

Biological Reagents and Cell Culture-Recombinant human IL-1␤
and TNF-␣ were provided by Genentech, Inc. (South San Francisco). The anti-Flag monoclonal antibody M2 and M2 cross-linked to Sepharose beads (M2 beads) were purchased from Sigma. Rabbit anti-Myc polyclonal antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). 293 cells and 293 sublines, HeLa, HepG2, and MRC-5 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum; Jurkat, U937, and THP-1 in RPMI with 10% fetal calf serum. U937 and THP-1 were differentiated in culture medium with either 50 nM TPA/ionomycin (Sigma) or 10 g/ml LPS (Sigma) for 48 h.
Cloning and Expression Vectors-IRAK-M cDNA was obtained from a phage library made of cDNA derived from human phytohemagglutinin-L-activated peripheral blood leukocytes in a low stringency hybridization using the EST clone AA840598 as a probe by following standard procedures (35) . Mammalian expression vectors encoding NH 2 -terminal Flag-tagged IL-1RI, TRAF6, IRAK, IRAK K239S, and hemagglutinin-tagged N-IRAK (amino acids 1-215) as well as COOHterminal Flag-tagged MyD88 have been described elsewhere (20) . The NF-B-dependent E-selectin-luciferase reporter plasmid pELAM-luc and pRSV-␤-gal have also been described (36, 37) . Constructs encoding COOH-terminal AU1-tagged IRAK-2, IRAK-2 K237A/K238A, and N-IRAK-2 (amino acids 1-95) were a kind gift of Vishva Dixit (19) . Expression vectors for NH 2 inserting polymerase chain reaction-generated cDNA fragments in the mammalian expression pRK7 (38) . IRAK-M K192A was constructed using the Quick-Change site-directed mutagenesis kit (Stratagene, La Jolla, CA).
RNA Preparation and Northern Blotting-Total RNA was isolated from various cell lines by guanidinium/phenol extraction (RNazol, Life Technologies) following the manufacturer's instructions. 20 g of RNA/ lane was separated on a 1.2% formaldehyde agarose gel and blotted to a nitrocellulose membrane (35) . The blot was stained with 0.04% methylene blue to monitor sample loading. Hybridization and prehybridization were carried out at 65°C in ExpressHyb solution (CLONTECH) following manufacturer-recommended procedures. Probes were labeled with [␣-32 P]dCTP using the random primer labeling kit (Amersham Pharmacia Biotech). Multiple tissue Northern blots were purchased from CLONTECH.
Reporter Assays-3 ϫ 10 5 293IL-1RI or 293I1A cells were seeded into six-well (35-mm) plates. Cells were transfected on the following day by the calcium phosphate precipitation method with 0.1 g of pELAM-luc and 1 g of pRSV-␤-gal and the indicated amounts of expression constructs. After 24 h, the cells were stimulated with IL-1␤ (20 ng/ml), TNF-␣ (100 ng/ml), or LPS (E. coli serotype 0111:B4, Sigma, 10 g/ml) for 6 -8 h before harvest. Luciferase activity and ␤-galactosidase activity were determined with the luciferase assay system (Promega) and chemoluminescence reagents from Tropix, respectively.
Immunoprecipitations and Immunoblotting-For coprecipitation of transfected proteins, 3 ϫ 10 6 293 or 293I1A cells were plated on 10-cm dishes and transfected on the following day with the indicated amounts of expression constructs. The total amount of DNA was kept constant in each transfection by adding empty vector. After 24 h, cells were collected, washed once with phosphate-buffered saline and lysed for 20 min on ice in 1 ml of lysis buffer containing 50 mM Hepes, pH 7.9, 250 mM NaCl, 20 mM ␤-glycerophosphate, 1 mM sodium orthovanadate, 5 mM p-nitrophenyl phosphate, 2 mM dithiothreitol, protease inhibitors (complete, Roche Molecular Biochemicals), and 1% Nonidet P-40. Cellular debris was removed by centrifugation twice at 15,000 ϫ g for 15 min. The cell lysate was incubated with 25 l of M2 beads (Sigma) for 2 h at 4°C with gentle rocking. After extensive washing with lysis buffer, proteins bound to the beads were either subjected to in vitro kinase assays (see below) or directly solubilized by boiling in SDS sample buffer, fractionated by SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride membrane, and blotted with the indicated antibodies. The reactive bands were visualized with horseradish peroxidase coupled to the appropriate secondary antibodies and the enhanced chemiluminescence (ECL) Western blotting detection system (Amersham Pharmacia Biotech).
In Vitro Kinase Assays-Washed immunoprecipitates were resuspended in 20 l of kinase buffer (20 mM Tris, pH 7.6, 1 mM dithiothreitol, 20 mM MgCl 2 , 20 mM ␤-glycerophosphate, 20 mM p-nitrophenyl phosphate, 1 mM EDTA, 1 mM sodium orthovanadate, protease inhibitors (complete, Roche Molecular Biochemicals), 20 M ATP) with (for autoradiography) or without (for Western analysis) 10 Ci of [␥-
32 P]ATP and incubated for 20 min at 37°C. The kinase reaction was stopped by boiling in 20 l of SDS sample buffer. Proteins were separated via SDS-polyacrylamide gel electrophoresis. The gels were either immunoblotted as described above or dried and exposed to x-ray films.
Computational Analysis-Sequences related to human IRAK were identified in the EST data base (dbEST) at the National Center for Biotechnology Information using the TFASTA program of the Wisconsin Package version 9.1 (Genetics Computer Group (GCG), Madison, WI). Pairwise sequence comparisons were performed with the GAP program of the Wisconsin Package and sequence alignments with the ClustalW function of MacVector version 6.0.1 (Oxford Molecular Group).
RESULTS
Identification of IRAK-M as a New Member of the IRAK/
Pelle Family-In an attempt to identify new signal transducers in Toll/IL-1R signaling pathways, we searched EST data bases for sequences similar to IRAK. A murine EST sequence (accession number AA840598) was found which encodes polypeptides sharing significant homology with IRAK. A screen of a human phytohemagglutinin-activated peripheral blood leukocyte cDNA library with this EST sequence resulted in the isolation of a full-length cDNA clone that encodes a protein with 596 amino acids and a calculated molecular mass of 68 kDa. Analysis of the deduced protein sequence revealed an NH 2 -terminal death domain (39) and a central kinase domain, similar to the domain structures of IRAK and IRAK-2 (Fig. 1) . The overall sequence similarity shared between the newly identified protein and the existing IRAK-like molecules is between 30 and 40% (Table I) . Because of its restricted expression pattern (see below), we termed this molecule IRAK-M. Expression Pattern of IRAK-M mRNA-Hybridization of multiple tissue Northern blots with a 32 P-labeled full-length IRAK-M cDNA revealed three different mRNA species, one of 2.5 kilobases and a doublet of Ϸ8 kilobases (Fig. 2A) . The size of the smallest RNA species matches the cDNA isolated in the library screen, whereas the nature of the 8-kilobase hybridizing bands is currently unknown. IRAK-M mRNA is detected predominantly in peripheral blood leukocytes and only in low amounts in other tissues. No message was detectable in brain, liver, thymus, and small intestine.
A Northern analysis of different cell lines indicates that unlike IRAK, which is expressed in all cell types examined, the expression of IRAK-M is limited to the monocytic cell lines U937 and THP-1. The expression of IRAK mRNA in THP-1 cells is enhanced significantly by TPA and ionomycin treatment, which induces the differentiation of THP-1 toward more mature macrophages. This suggests a possible role of IRAK-M in immune effector functions (Fig. 2B) . Trace amounts of IRAK-M mRNA were found in the fibroblast cell line MRC-5, but no message was detected in 293, HeLa (epithelial), HepG2 (hepatoma) or Jurkat (T-cell) cell lines. IRAK-2 is expressed in most cell lines, albeit at low levels in HeLa and Jurkat. IRAK-2 expression is also strongly up-regulated in THP-1 cells by TPA/ionomycin. NF-B Activation by IRAK Family Members-It was shown previously that overexpression of either IRAK or IRAK-2 activates NF-B and that overexpression of the death domaincontaining NH 2 terminus of either protein has a dominant negative effect on IL-1-induced NF-B activation (19, 20, 40) . To investigate the ability of IRAK-M to activate NF-B, we transiently transfected 293 cells stably expressing IL-1RI (293IL-1RI cells; 21) with different amounts of IRAK-M expression plasmids together with an NF-B-dependent luciferase reporter construct (Fig. 3A) . Overexpression of IRAK-M activated NF-B in a dose-dependent fashion. The potency and efficacy of IRAK-M in this assay are similar to IRAK-2 but lower than IRAK (for a comparison of expression levels, see Fig.  4 and Fig. 5, bottom panels) .
Overexpression of the death domains of all three IRAK proteins inhibited IL-1-induced NF-B activation, yet had a minimal effect on the 10-fold TNF-induced NF-B activation (Fig.  3B) . The NH 2 terminus of IRAK was most potent: 3 ng of transfected plasmid reduced IL-1-induced luciferase activity by 50%. 100 ng of IRAK-2 or 400 ng of IRAK-M was needed to obtain the same effect, although the expression levels of the three constructs were similar (data not shown). The similarity shared by the three proteins in the NF-B reporter assays provides functional confirmation that IRAK-M is a member of the IRAK family.
Interaction of IRAK Family Members with MyD88 and TRAF6 -IRAK exerts its function in IL-1 signaling by interacting with the upstream adaptor protein MyD88 and the downstream signal transducer TRAF6 (20, 25) . IRAK-2 has also been shown to interact with MyD88 and TRAF6 upon overexpression (19) . We investigated whether IRAK-M is capable of interacting with the same molecules. Myc-tagged wild type or kinase-inactive forms of IRAK, IRAK-2, or IRAK-M were expressed in 293 cells alone or together with Flag-tagged MyD88 (Fig. 4A) . Immunoblotting analysis of the anti-Flag immunoprecipitates showed that mutant IRAK as well as both wild type and mutant IRAK-M and IRAK-2 can associate with MyD88 with a comparable efficiency. Wild type IRAK becomes phosphorylated upon overexpression and does not interact with MyD88.
We then examined if IRAK-M can bind to TRAF6 in a similar transfection experiment. Myc-tagged IRAK-M coprecipitated with Flag-tagged TRAF6 in an amount comparable to IRAK and IRAK-2 (the coprecipitation of IRAK wild type with TRAF6 was omitted because TRAF6 expresses poorly when coexpressed with wild type IRAK) (Fig. 4B) . The interaction of IRAK-M with MyD88 and TRAF6 further indicates that it is able to play a role in signal transduction similar to that of IRAK and IRAK-2.
Interactions among IRAK Family Members-We investigated the ability of IRAK-M, IRAK, and IRAK-2 to form homoor heterocomplexes in a transient transfection assays. Myctagged wild type or kinase-inactive mutants of IRAK, IRAK-2, and IRAK-M were expressed in 293 cells either alone or together with their Flag-tagged versions in all possible combinations. Anti-Flag immunoprecipitates of transfected cells were then immunoblotted to detect coprecipitating Myc-tagged proteins. Although the interactions between wild type IRAK and any other IRAK proteins were relatively weak because of the lower levels of expression, all possible homo-and heterocomplex formations were readily detectable (Table II) , suggesting that the three IRAK proteins may form complexes in cells where they are coexpressed.
Analysis of Kinase Activity of IRAK Family Members-IRAK possess a pronounced kinase activity and can undergo heavy autophosphorylation after IL-1 stimulation in cells (21, 24) . To compare kinase activities of IRAK-M, IRAK, and IRAK-2, Flagtagged wild type or the kinase-defective forms of the three proteins were transiently expressed in a 293 cell line deficient for IRAK (293l1A; 41) to avoid coprecipitation of endogenous IRAK. The epitope-tagged proteins were immunoprecipitated with anti-Flag M2 beads and tested for their autophosphorylation activity. Wild type IRAK was heavily phosphorylated, as indicated by its reduced electrophoretic mobility (Fig. 5, bottom  panel) and its strong labeling by [ 32 P]ATP (Fig. 5, top panel) . As expected, IRAK K239S did not undergo autophosphorylation (Fig. 5) . Surprisingly, neither wild type IRAK-M nor wild type IRAK-2 was able to autophosphorylate like IRAK. After a long exposure, faint radiolabeled bands with retarded mobility were detected in the sample containing the wild type IRAK-M (Fig.  5, middle panel) , indicating that this protein may have a weak kinase activity, but we were unable to detect any kinase activity of IRAK-2.
We then asked if IRAK-M and IRAK-2 can be phosphorylated and/or activated by IRAK. Flag-tagged wild type or kinasedefective IRAK-M, IRAK, or IRAK-2 was cotransfected with untagged IRAK into IRAK-deficient 293I1A cells. Each Flagtagged protein coprecipitated the untagged IRAK that underwent autophosphorylation (Fig. 5, right panel) . Coprecipitated IRAK efficiently phosphorylated IRAK Lys 3 Ser, as indicated by the shift of its electrophoretic mobility (bottom panel) and its heavy 32 P labeling. In comparison, IRAK-M and IRAK-2 are not as good substrates as IRAK. But it is remarkable that the wild type IRAK-M and IRAK-2 are phosphorylated more strongly than their corresponding Lys 3 Ala mutants, raising the possibility that IRAK-M and IRAK-2 may be activated by IRAK and then undergo autophosphorylation.
Restoration of IL-1 Response in IRAK-deficient 293 Cells-It has been shown recently that the IRAK-deficient 293I1A cells can no longer respond to IL-1, and this defect can be restored by IRAK or IRAK-2 (41) . To test if IRAK-M can mediate an IL-1 response in the absence of IRAK, we transiently transfected 293I1A cells with different amounts of IRAK-M expression vector along with a NF-B-dependent luciferase reporter construct. Similar to IRAK-2, IRAK-M can also supplement for the loss of IRAK to restore IL-1 response (Fig. 6A) . However, neither IRAK-2 or IRAK-M is as efficacious as IRAK in this assay. Transfection of 293I1A cells with an expression vector for re- ceptor interacting protein, a type I TNF receptor-associated kinase (42) , failed to restore the IL-1 response, showing that the IRAK effects were specific (data not shown). These results indicate that the three IRAK-like proteins can at least partially substitute for one another in signaling.
Restoration of LPS Response in IRAK-deficient Cells-TLR-2, a member of the Toll/IL-1R superfamily, has recently been shown to mediate LPS-induced NF-B activation in 293 cells (9, 12) . Because of the sequence similarity shared by the intracellular domains of TLR-2 and IL-1RI/IL-1RAcP, it has been speculated that the intracellular signal transducers for IL-1 might also participate in TLR-2 signaling. Supporting this hypothesis, the IRAK-deficient 293I1A cells that fail to respond to IL-1 also fail to mount a TLR-2-mediated LPS response (Fig.  6B) . Transfection of expression plasmids for any of the three IRAK proteins regenerated the LPS response in the luciferase reporter assay (Fig. 6B) , again suggesting that these proteins share similar functional properties. This IRAK-mediated LPS response is dependent on TLR-2, as 293I1A transfected with IRAK failed to respond to LPS in the absence of TLR-2 (data not shown).
DISCUSSION
Members of the Toll/IL-1R family of transmembrane receptors play an important role in various immune responses (3, 5, 9, (11) (12) (13) . Supported by both biochemical and genetic studies, many members of this receptor family engage similar intracellular signal transducers to generate cellular response (see the Introduction). In this study, we present for the first time genetic evidence for the involvement of IRAK in LPS signaling. The IRAK-deficient cell line 293I1A failed to respond to IL-1 as well as to LPS, and this defect can be corrected by introducing exogenous IRAK or IRAK-related proteins back into the cells. These results support an emerging scheme that the IL-1 intracellular signaling mechanism may be common to a class of receptors that share sequence homology with the IL-1 receptors.
The observation that IRAK-deficient mice and cells retain significant residual IL-1 and IL-18 response (33, 34) The three IRAK-like proteins are unlikely to play completely redundant roles in animals. In contrast to IRAK and IRAK-2, whose mRNA is detected in multiple tissues and cell types, the expression of IRAK-M is limited mostly to cells of the monocytic lineage and is up-regulated during differentiation, suggesting a cell type-specific function of IRAK-M.
The most striking feature that distinguishes IRAK from the other IRAK-like proteins is its potent autophosphorylation, which is not detected in IRAK-M and IRAK-2. Nevertheless, both IRAK-M and IRAK-2 are able to transduce IL-1-and LPS-mediated signals in the absence of IRAK. Assuming that autophosphorylation reflects the kinase activity, it is possible that the role of IRAK in signal transduction is not phosphorylating downstream targets. In nontransfected cells, IRAK autophosphorylation is detected only after IL-1 stimulation. Based on the observation that the phosphorylated form of IRAK is unable to bind to MyD88, which links IRAK to the receptor complex (20) , we speculated that the phosphorylation of IRAK may trigger its release from the receptor complex and its subsequent interaction with TRAF6. If this assumption were correct, the requirement of the IRAK kinase activity in signaling would not be apparent in transfection experiments because of protein overexpression, which results in a high concentration of free IRAK. Consistent with this scenario, forms of IRAK proteins harboring mutations in their ATP binding pockets could still activate NF-B upon overexpression in 293 cells, albeit with a lower potency (data not shown). Alternatively, the role of IRAK kinase activity may be to regulate IL-1 signaling negatively after cytokine induction. Supporting this hypothesis, IRAK phosphorylation is followed by its proteolytic degradation (24) . Careful comparison of the duration of the IL-1 response in cells expressing physiological amounts of the wild type IRAK or the kinase-deficient form of IRAK will help to distinguish between these possibilities. Although IRAK-2 and IRAK-M have very low autophosphorylation activity on their own, the wild type forms can be phosphorylated better than their corresponding kinase-inactive mutants in the presence of IRAK (Fig. 5) . Under the assumption that the mutation of a single amino acid residue in the ATP binding pocket does not transform IRAK-M or IRAK-2 into a poorer substrate for IRAK, it is reasonable to speculate that IRAK phosphorylates IRAK-2 and IRAK-M, thereby activating the intrinsic kinase activity of these molecules. Mapping the sites on IRAK-2 and IRAK-M which are phosphorylated by IRAK in combination with site-directed mutagenesis should help to address this issue.
Our study shows that IRAK is more potent and efficacious than the other two IRAK-like proteins at restoring IL-1 and LPS responses in 293I1A cells. Although we cannot exclude that IRAK-M and IRAK-2 mainly participate in the signaling of other related receptors, our observations raise the possibility that IRAK may be the primary signal transducer. Because IRAK-2 and IRAK-M can form heterocomplexes with IRAK, they may help to amplify the cytokine signals by providing a critical mass. Under this scenario, the expression levels of IRAK-like molecules would influence the degree of the response of a given cell type to a set of cytokines such as IL-1, IL-18, or LPS.
